Profile data is unavailable for this security.
About the company
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
- Revenue in INR (TTM)11.51bn
- Net income in INR2.01bn
- Incorporated1967
- Employees1.41k
- LocationProcter & Gamble Health LtdGodrej One,8Th Floor Pirojshanagar, Vikhroli (East)MUMBAI 400079IndiaIND
- Phone+91 2 262109000
- Fax+91 2 262109999
- Websitehttps://www.pghealthindia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Supriya Lifescience Ltd | 5.99bn | 1.35bn | 45.46bn | 448.00 | 33.62 | -- | 29.95 | 7.59 | 16.80 | 16.80 | 74.42 | -- | -- | -- | -- | 13,370,000.00 | -- | 19.08 | -- | 24.04 | 62.75 | 57.12 | 22.58 | 24.71 | -- | 92.47 | -- | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| RPG Life Sciences Limited | 6.00bn | 923.20m | 46.42bn | 1.27k | 50.28 | -- | 42.02 | 7.74 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Aarti Drugs Ltd | 24.23bn | 1.57bn | 46.54bn | 1.06k | 29.85 | -- | 22.25 | 1.92 | 17.08 | 17.08 | 263.82 | -- | -- | -- | -- | 22,770,740.00 | -- | 9.73 | -- | 15.78 | 34.32 | 22.23 | 6.48 | 8.25 | -- | 7.28 | -- | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Morepen Laboratories Ltd | 17.45bn | 1.18bn | 47.98bn | 1.62k | 37.90 | -- | 32.07 | 2.75 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| SeQuent Scientific Ltd | 14.27bn | 54.87m | 48.02bn | 1.20k | 901.99 | -- | 61.82 | 3.37 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Unichem Laboratories Ltd | 17.28bn | -605.50m | 50.04bn | 3.19k | -- | -- | 95.77 | 2.90 | -8.59 | -8.59 | 245.15 | -- | -- | -- | -- | 5,410,587.00 | -- | -1.67 | -- | -2.03 | 62.00 | 56.18 | -3.50 | -3.99 | -- | 0.1401 | -- | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
| Aarti Pharmalabs Ltd | 19.50bn | 2.25bn | 54.96bn | 1.63k | 24.40 | -- | 18.23 | 2.82 | 24.86 | 24.86 | 215.17 | -- | -- | -- | -- | 11,983,730.00 | -- | -- | -- | -- | 44.20 | -- | 11.55 | -- | -- | 18.55 | -- | -- | -4.76 | -- | 12.10 | -- | -- | -- |
| Sun Pharma Advanced Research Co Ltd | 684.05m | -3.89bn | 69.18bn | 409.00 | -- | -- | -- | 101.13 | -11.97 | -11.97 | 2.11 | -- | -- | -- | -- | 1,672,501.00 | -- | -61.70 | -- | -119.31 | 59.81 | 74.49 | -568.24 | -163.40 | -- | -208.33 | -- | -- | -68.36 | -16.21 | -73.96 | -- | 15.40 | -- |
| Orchid Pharma Ltd | 8.81bn | 1.12bn | 70.60bn | 872.00 | 60.82 | -- | 48.18 | 8.02 | 22.89 | 22.89 | 180.65 | -- | -- | -- | -- | 10,101,540.00 | -- | -0.9734 | -- | -1.40 | 40.67 | 40.74 | 12.78 | -2.40 | -- | 6.08 | -- | -- | 23.05 | 6.43 | 73.59 | 5.84 | 57.79 | -- |
| Shilpa Medicare Ltd | 11.84bn | 447.57m | 85.31bn | 931.00 | 174.64 | -- | 55.73 | 7.21 | 5.00 | 5.00 | 133.55 | -- | -- | -- | -- | 12,716,850.00 | -- | 2.84 | -- | 3.65 | 65.19 | 60.08 | 3.79 | 7.03 | -- | 1.56 | -- | 10.76 | 9.66 | 9.44 | 198.15 | -22.26 | -9.26 | -- |
| Procter & Gamble Health Ltd | 11.51bn | 2.01bn | 86.90bn | 1.41k | 43.26 | 16.15 | 38.05 | 7.55 | 121.01 | 121.01 | 693.20 | 324.24 | 1.21 | 2.71 | 11.45 | -- | 21.21 | -- | 29.28 | -- | 71.29 | -- | 17.46 | -- | 1.90 | 386.94 | 0.0175 | -- | -6.37 | -- | -12.42 | -- | -- | -- |
| F D C Ltd | 20.45bn | 3.14bn | 87.30bn | 6.66k | 27.91 | -- | 24.55 | 4.27 | 19.21 | 19.21 | 124.56 | -- | -- | -- | -- | 3,070,786.00 | -- | 12.05 | -- | 13.73 | 65.55 | 61.54 | 15.37 | 15.85 | -- | 75.15 | -- | 1.09 | 8.92 | 12.24 | 57.30 | 12.45 | 16.93 | -- |
| Blue Jet Healthcare Ltd | 6.95bn | 1.57bn | 90.75bn | 447.00 | 57.64 | -- | 49.61 | 13.06 | 9.08 | 9.08 | 40.07 | -- | -- | -- | -- | 15,547,110.00 | -- | -- | -- | -- | 55.54 | -- | 22.65 | -- | -- | 124.37 | -- | -- | -1.30 | -- | 2.33 | -- | -- | -- |
| Sanofi Consumer Healthcare India Ltd | 8.01bn | 2.31bn | 112.90bn | -- | 48.94 | 61.16 | 48.18 | 14.10 | 100.17 | 100.17 | 347.67 | 80.15 | -- | -- | -- | -- | -- | -- | -- | -- | 71.64 | -- | 28.81 | -- | 2.27 | 3,260.00 | 0.0986 | -- | -- | -- | -- | -- | -- | -- |
Data as of Oct 11 2024. Currency figures normalised to Procter & Gamble Health Ltd's reporting currency: Indian Rupee INR
16.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Sep 2023 | 596.81k | 3.60% |
| ICICI Prudential Asset Management Co. Ltd.as of 31 Jul 2024 | 433.40k | 2.61% |
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Sep 2023 | 399.97k | 2.41% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Sep 2023 | 338.85k | 2.04% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 31 Jul 2024 | 314.23k | 1.89% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 273.28k | 1.65% |
| DSP Asset Managers Pvt. Ltd.as of 30 Jun 2024 | 158.70k | 0.96% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 118.94k | 0.72% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 101.31k | 0.61% |
| Sundaram Asset Management Co. Ltd.as of 31 Jul 2024 | 85.07k | 0.51% |
More ▼
Data from 31 Mar 2024 - 08 Aug 2024Source: FactSet Research Systems Inc.
